Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.870
+0.040 (2.19%)
Jan 22, 2026, 2:35 PM EST - Market open
Vivos Therapeutics Market Cap
Vivos Therapeutics has a market cap or net worth of $17.65 million as of January 22, 2026. Its market cap has decreased by -31.43% in one year.
Market Cap
17.65M
Enterprise Value
26.68M
1-Year Change
-31.43%
Ranking
Category
Stock Price
$1.87
Market Cap Chart
Since the IPO on December 11, 2020, Vivos Therapeutics's market cap has decreased from $103.52M to $17.65M, a decrease of -82.95%. That is a compound annual growth rate of -29.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 17.27M | -5.34% |
| Dec 31, 2025 | 18.25M | -27.79% |
| Dec 31, 2024 | 25.27M | 69.64% |
| Dec 29, 2023 | 14.89M | 61.00% |
| Dec 30, 2022 | 9.25M | -82.13% |
| Dec 31, 2021 | 51.78M | -50.41% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 11, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 289.32B |
| Novartis AG | 278.23B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 261.50B |